Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

AIMab 7195

Next Previous
Drug Profile

AIMab 7195

Alternative Names: AIMab-7195; XmAb® 7195

Latest Information Update: 24 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xencor
  • Developer Aimmune Therapeutics; Xencor
  • Class Antiallergics; Antiasthmatics; Food allergy immunotherapies; Immunotherapies; Monoclonal antibodies
  • Mechanism of Action Fc gamma receptor IIB antagonists; IgE receptor antagonists; Immunoglobulin E inhibitors; Immunosuppressants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Food hypersensitivity
  • Discontinued Allergic asthma; Allergic rhinitis; Atopic dermatitis; Conjunctivitis

Most Recent Events

  • 31 Dec 2024 AIMab 7195 is no longer licensed to Aimmune Therapeutics worldwide
  • 05 Oct 2023 AIMab 7195 is still in phase I trial for Food-hypersensitivity in USA (Parenteral) (Xencor pipeline, October 2023)
  • 14 Oct 2020 Aimmune Therapeutics has been acquired by Nestle

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top